SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-065270
Filing Date
2018-12-19
Accepted
2018-12-19 07:00:39
Documents
2
Effectiveness Date
2018-12-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv509397_defa14a.htm DEFA14A 18664
2 GRAPHIC image_001.jpg GRAPHIC 5532
  Complete submission text file 0001144204-18-065270.txt   27665
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33357 | Film No.: 181242189
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1